L. Xia

Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation

R. Kong, Xie-wan Chen, Jianguo Sun, 2016, Oncotarget.

Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1

Jianguo Sun, Zhengtang Chen, Feng Li, 2020, BMC cancer.

Oncogenic miR-20b-5p contributes malignant behavior via bidirectionally regulating CCND1 and E2F1 in breast cancer stem cells

Jianguo Sun, Zhengtang Chen, Feng Li, 2020 .

Continued EGFR-TKI with concurrent radiotherapy to improve time to progression (TTP) in patients with locally progressive non-small cell lung cancer (NSCLC) after front-line EGFR-TKI treatment

Y. Wang, J. Sun, R. Kong, 2018, Clinical and Translational Oncology.

Phosphatase and tensin homolog deleted on chromosome 10 degradation induced by NEDD4 promotes acquired erlotinib resistance in non–small-cell lung cancer

Jianguo Sun, Zhengtang Chen, L. Xia, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Bronchiolar adenoma in the right upper lobe of the lung: A case report.

L. Xia, 2023, Asian journal of surgery.